Please login to the form below

Not currently logged in
Email:
Password:

malaria

This page shows the latest malaria news and features for those working in and with pharma, biotech and healthcare.

Evotec says Sanofi deal makes it anti-infectives powerhouse

Evotec says Sanofi deal makes it anti-infectives powerhouse

regulatory approvals of course – and that will give it “the highest qualified translational footprint in infectious disease research globally.”It will focus initially on antimicrobial resistant (AMR) infections, tuberculosis, and malaria,

Latest news

More from news
Approximately 22 fully matching, plus 110 partially matching documents found.

Latest Intelligence

  • Waking the sleeping giant Waking the sleeping giant

    In Uganda, a malaria-specific app provides questions and answers relating to that disease, while in Mozambique another app greatly increases the efficacy of immunisation programmes by reminding users via text

  • The three forces behind the re-imagining of patient care The three forces behind the re-imagining of patient care

    developing a device that can detect malaria and give you a result in two minutes.

  • Opening up innovation Opening up innovation

    For GlaxoSmithKline its pharma open innovation efforts began with diseases of the developing world, such as malaria - where it offered researchers free access to a 'virtual library' of tens of thousands

  • Aiming high for women Aiming high for women

    6. Halt and start to reverse the spread and incidence of HIV/AIDS, malaria and other diseases - MISSED, although the number of new HIV/AIDS infections fell by 40% in

  • Deal Watch February 2016 Deal Watch February 2016

    Alere has annual sales of approximately $2.5bn from a portfolio of point-of-care products in areas including cardiometabolic, infectious diseases such as HIV, malaria, syphilis, E. ... acquisition - company. 7, 200. Alere/Abbott Laboratories. portfolio

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest appointments

  • Former PEPFAR head Mark Dybul to lead the Global Fund Former PEPFAR head Mark Dybul to lead the Global Fund

    Former PEPFAR head Mark Dybul to lead the Global Fund. Joins at time of change for the AIDS, tuberculosis and malaria focused non-profit organisation. ... The Global Fund to Fight AIDS, Tuberculosis and Malaria has appointed renowned AIDS expert Dr Mark

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics